Navigation Links
A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
Date:10/25/2007

Seventy-eight percent of psychiatrists and parents provide different

responses when asked about patients' 'most concerning behavior'

ORLANDO, Fla., Oct. 25 /PRNewswire/ -- According to a small-scale, in-office, observational study, psychiatrists and parents have significantly different perceptions of the importance of pediatric ADHD and psychiatric comorbidities, particularly regarding the patients' most concerning behavior. The study, which utilized accepted sociolinguistic methodologies to evaluate the tone, content and structure of in-office visits, was presented recently at the 20th annual U.S. Psychiatric and Mental Health Congress (USPMHC).

"We found that among the psychiatrists and parents studied, 78 percent provided different responses when asked about the patient's 'most concerning behavior,'" said Robert Findling, M.D., lead author and professor of psychiatry at Case Western Reserve University and director of the division of child and adolescent psychiatry at University Hospitals Case Medical Center. "There was a notable incidence of psychiatrist/parent misalignment regarding the patients' most concerning behaviors, including aggression and defiance."

The study, designed to capture naturally occurring conversations between psychiatrists, patients with ADHD and their parents, consisted of eleven psychiatrists, thirty-two child and adolescent ADHD patients and their parents. Half of the patients were younger than 13 years old, and the majority fulfilled the criteria of "complicated ADHD," which was defined in the study as a patient "having or suspected to have one or more psychiatric comorbidities." Physicians classified 81 percent of patients as having one or more psychiatric comorbidities/learning disabilities. The most common comorbidities greater than 20 percent included: depression (46 percent), oppositional defiant disorder (42 percent), anxiety (38 percent), learning disabilities (35 percent) and bipolar disorder (23
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
6. Haemacure Announces Preliminary Findings of its Plasma Discard Analysis
7. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
10. Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
11. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2008)... - Clinical trial currently in Phase I -, .../ -- Tobira,Therapeutics Inc., a clinical stage bi...product discovery against life-threatening and lif...e issuance of Patent No. 7,371,772,B2 by the U.S. ...BR-652, a,CCR5 antagonist currently in Phase I dev...
(Date:8/17/2008)..., Australia, Aug. 17 /Xinhua-PRNewswire-FirstCall/...nced that the first pivotal Phase 3,clinical trial...s has,completed enrolment., The first efficacy da...ng the first half of 2009. The trial commenced its...ecruitment target of 250 subjects in June,2008 and...
(Date:8/14/2008)...ORE, Aug. 15 /- AstraZeneca...artnership with the National Cancer,Centre Singapo...H) to,develop anti-cancer compounds. The collabora...tanding (MOU) that was signed today, aims to furth...es in Asia and ultimately,speed up access to new m...
(Date:8/14/2008)...TON, N.J., Aug. 14 /- Pharm...rmaceutical company committed to,discovering, deve...ral,infections, reported unaudited financial resul...8. Pharmasset reported a net loss attributable to,...r share of $0.69 for the,quarter ended June 30, 20...
Breaking Medicine Technology:Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference 5596 1New CDC Study Shows Smoke Free Laws Spreading Across U S and Should Spur Remaining States to Take Action 20109 1New CDC Study Shows Smoke Free Laws Spreading Across U S and Should Spur Remaining States to Take Action 20109 2New CDC Study Shows Smoke Free Laws Spreading Across U S and Should Spur Remaining States to Take Action 20109 3Pioneer 28R 29 Surgical Technology Introduces the BacJac 28TM 29 Interspinous Decompression System to the European Spine Market 20104 1Pioneer 28R 29 Surgical Technology Introduces the BacJac 28TM 29 Interspinous Decompression System to the European Spine Market 20104 2Major missed biochemical pathway emerges as important in virtually all cells 20103 1Major missed biochemical pathway emerges as important in virtually all cells 20103 2Major missed biochemical pathway emerges as important in virtually all cells 20103 3
...and Drug Administration,(FDA) is aware of a potent...), a drug approved to treat type 2 diabetes. Safet...that there is a,potentially significant increase i...s in patients taking Avandia. However, other,publi...trials of,Avandia, including an interim analysis o...
.../ -- Wyeth (NYSE: WYE),today announced that the U....istrict Office has informed the Company that the r...o manufacturing,facility has resulted in a positiv...cation means that any issues found by the FDA have...rit any further,regulatory action. Guayama will co...
Other Medicine Technology:FDA Issues Safety Alert on Avandia 2FDA Issues Safety Alert on Avandia 3FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 2FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 3
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...nti-inflammatory drug Dicolofenec on the country's...as decided to withdraw licences for manufacturing ...ay, the director of the prominent NGO Bombay Natur...ani, presented a copy of Drug Controller General A...
...at the grapes in most red wines have a sleep induc...son why wine lulls //people to beauty sleep. Melat...and in the brain, which is like a sign board for t... The discovery of melatonin in grape skin could e...
... a curse many men suffer, is thankfully out of the...t ED, //many men are finding solutions to their pr...r sexual dysfunction, it is increasingly important...cialties to become proficient in the mechanisms an...
...the lives of wild and laboratory rodents seems to ...une systems when exposed //to germs in the environ...of researchers from Duke University analyzed the i...s which live in laboratories with those which live...
Other Medicine News:Health News:Host of Benefits from Erectile Dysfunction Drugs 2Health News:Host of Benefits from Erectile Dysfunction Drugs 3
...feature full monochromatic and chromatic correctio...illiant, rich-contrast, completely flat images for...ed-light methods. Their high transmission of wavel...e of glass types of low autofluorescence makes the...
Inquire
Epiplan-Neofluar objectives is a series of objectives for the examination of materials. They differ from Epiplan objectives by their higher NA and, accordingly, higher resolving power. Unlike the Epi
...ransmission rate, especially in the ultraviolet, a...mat series, these objectives are designed for fluo...e of improved quality, these objectives can functi...orescence, polarising and DIC observations. The DL...
Medicine Products: